Analystreport

KALA BIO (NASDAQ:KALA) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.

KALA BIO, Inc.  (KALA) 
Last kala bio, inc. earnings: 2/12 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.kalarx.com